KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $6,976,000 | -9.6% | 2,051,899 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $7,715,000 | -8.1% | 2,051,899 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $8,393,000 | -12.0% | 2,051,899 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $9,541,000 | -34.5% | 2,051,899 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $14,568,000 | +0.5% | 2,051,899 | +2.3% | 0.01% | 0.0% |
Q2 2017 | $14,502,000 | +38.3% | 2,005,796 | +17.9% | 0.01% | +50.0% |
Q1 2017 | $10,484,000 | +5.1% | 1,701,935 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $9,973,000 | +15.5% | 1,701,935 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $8,632,000 | -23.4% | 1,701,935 | 0.0% | 0.00% | -20.0% |
Q2 2016 | $11,267,000 | +41.8% | 1,701,935 | 0.0% | 0.01% | +25.0% |
Q1 2016 | $7,948,000 | -13.1% | 1,701,935 | -6.1% | 0.00% | -20.0% |
Q4 2015 | $9,150,000 | +175.9% | 1,811,935 | +92.4% | 0.01% | +150.0% |
Q3 2015 | $3,316,000 | -64.7% | 941,935 | 0.0% | 0.00% | -60.0% |
Q2 2015 | $9,401,000 | +22.0% | 941,935 | +55.6% | 0.01% | +25.0% |
Q1 2015 | $7,708,000 | – | 605,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |